6-methylflavone exerts selective antimycobacterial activity with membrane energetics disruption and demonstrates therapeutic potential against <i>Mycobacterium abscessus</i> infection. [PDF]
Microbiol SpectrOh J +5 more
europepmc +1 more source
Evaluation of In Vitro Effects of Fosfomycin in Combination With Amikacin and Ciprofloxacin Against Multidrug-Resistant Escherichia coli Isolates. [PDF]
CureusChoudhury S +4 more
europepmc +1 more source
Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]
BMC Health Serv ResYang J +6 more
europepmc +1 more source
Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment. [PDF]
New Microbes New InfectHongler J +10 more
europepmc +1 more source
Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study. [PDF]
BMC Pulm MedWakabayashi H +5 more
europepmc +1 more source
Successful treatment of pneumonia due to <i>Mycobacterium goodii</i> in a severely underweight 45-year-old woman: case report and review of literature. [PDF]
New Microbes New InfectCatania F +5 more
europepmc +1 more source
Physical compatibility of omadacycline with intravenous agents used in the treatment of Mycobacteroides abscessus pulmonary disease. [PDF]
Am J Health Syst PharmButler DA, Moolick K.
europepmc +1 more source
Characterizing the Profiles of Gram-Negative Bacterial Pathogens of Wound Infections and Their Drug-Resistance Disposition. [PDF]
MicroorganismsBadger-Emeka L.
europepmc +1 more source
From Needle to Sachet: Fosfomycin Versus Amikacin for Cystoscopy Prophylaxis. [PDF]
CureusQuadir U +9 more
europepmc +1 more source